Year of Establishment: 1963
IndiaMART Member Since: 2009
Samarth has evolved into an innovative global life science company that explores, develops, manufactures and markets a broad range of life saving critical care drugs. The company has earned respect and customer loyalty by combining highly specialized skill sets-such as therapeutic area expertise and an understanding of global and local regulatory environments - with an uncommon dedication to providing superlative service. We aim at exponential growth through expansion in new therapeutic area and exploring new molecules. As indian pharma companies race to bring new chemical entities to the global marketplace, samarth has established itself as a market driven; technology based company with a strong r & d base and is aiming at creating a niche market for products which are mostly import substitutes and life saving health care products. In it's pioneering spirit samarth took a lead role in establishing a footprint in India in the year of 1963 from humble beginnings and has today developed into a multi dimensional, multi location pharmaceutical conglomerate. Together, our 750 specialized employees play an unequaled role in improving health care by providing a broad range of professional services, information & marketing life saving molecules to leading doctors in India. We have set up a marketing network that understands & responds to the customer's need and in the process, we also inculcate a high performance organizational culture. Our flagship brands adrenor, mucomix, Canadian, distinon, urotone, cpressin, insed atomizer have gained wide credibility and acceptance among the medical fraternity and have become brand leaders in their respective segments. Exports are also thriving and our products find place on the shelves of markets in south america, u. K, south east Asian countries and many African states. An isolated and dedicated state-of-art production facility for development of oncology drugs with advanced liposomal technology has been commissioned. To enhance the capacities for meeting the growing demands the company has set up a separate unit for developing & manufacturing highly potent hormones. We take pride in featuring amongst one of the few companies that engage in manufacture of both pre-filled syringes & lyophilized products. Every step of manufacturing process & equipment used are compliant with the stringent who gmp requirements. As part of our expansion plans, we intend setting up a backward integration plant for bulk drugs as well as a new state of the art who gmp formulation unit. Successful operations, backed by strong infrastructure framework have accelerated samarth's growth from oblivience to a turnover of us $15 million and shall continue to strive to produce quality drugs at affordable prices. We constantly challenge ourselves to be a step ahead in terms of quality and personalized services.
Please provide your contact details
Send your enquiry to this supplier
Buyers Tool KitSend Buy Requirement
Suppliers Tool KitPost Products - FREE
Mobile Channel: Connect with us: